These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11122822)

  • 1. Novel oral chemotherapy agents.
    Royce ME; Hoff PM; Pazdur R
    Curr Oncol Rep; 2000 Jan; 2(1):31-7. PubMed ID: 11122822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
    Cunningham D; Coleman R
    Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral fluoropyrimidines: are they the equivalent of parenteral infusional 5-fluorouracil?
    Lokich J
    Cancer Invest; 2001; 19(8):854-7. PubMed ID: 11768039
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer.
    Cunningham D; James RD
    Eur J Cancer; 2001 May; 37(7):826-34. PubMed ID: 11313169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral fluoropyrimidines: a closer look at their toxicities.
    Macdonald JS
    Am J Clin Oncol; 1999 Oct; 22(5):475-80. PubMed ID: 10521062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral fluoropyrimidines in oncology].
    González Barón M
    An R Acad Nac Med (Madr); 1998; 115(3):721-45; discussion 745-6. PubMed ID: 10208021
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorectal cancer: chemotherapy treatment overview.
    Royce ME; Medgyesy D; Zukowski TH; Dwivedy S; Hoff PM; Pazdur R
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):40-6. PubMed ID: 11200148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in systemic chemotherapy in advanced colorectal cancer.
    Cats A
    Scand J Gastroenterol Suppl; 2003; (239):78-86. PubMed ID: 14743888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of colorectal cancer metastasis: the role of chemotherapy.
    Xiong HQ; Ajani JA
    Cancer Metastasis Rev; 2004; 23(1-2):145-63. PubMed ID: 15000155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral fluoropyrimidines in colorectal cancer.
    Van Cutsem E; Peeters M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation.
    Ward S; Kaltenthaler E; Cowan J; Brewer N
    Health Technol Assess; 2003; 7(32):1-93. PubMed ID: 14604497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluoropyrimidines in cancer treatment.
    Lewis NL; Meropol NJ
    Cancer Invest; 2000; 18(8):747-60. PubMed ID: 11107445
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral fluoropyrimidines in the treatment of colorectal cancer.
    Meropol NJ
    Eur J Cancer; 1998 Sep; 34(10):1509-13. PubMed ID: 9893621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus intravenous fluoropyrimidines for colorectal cancer.
    Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colorectal cancer: irinotecan in combination with newer drugs].
    Falcone A
    Tumori; 2001; 87(6):A31-3. PubMed ID: 11995705
    [No Abstract]   [Full Text] [Related]  

  • 16. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
    Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical considerations in the use of oral fluoropyrimidines.
    Hoff PM
    Semin Oncol; 2003 Jun; 30(3 Suppl 6):88-92. PubMed ID: 12802799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.
    Milano G; Ferrero JM; François E
    Br J Cancer; 2004 Aug; 91(4):613-7. PubMed ID: 15280932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral therapy for colorectal cancer: how to choose.
    Damjanov N; Meropol NJ
    Oncology (Williston Park); 2000 Jun; 14(6):799-807; discussion 807-8, 813-4,. PubMed ID: 10887632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.
    Corvò R; Pastrone I; Scolaro T; Marcenaro M; Berretta L; Chiara S
    Tumori; 2003; 89(4):361-7. PubMed ID: 14606636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.